ALXO vs IQV · $207.2M cap vs P/E 23, rev $16.31B
Alx Oncology Holdings (ALXO) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
Alx Oncology Holdings (ALXO) is a biotechnology company listed on US.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
ALXO does not have a complete income-statement cache yet.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
ALXO currently screens at market cap $207.2M. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the ALXO and IQV stock pages for the full models.
Not investment advice.